Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-२.६९%
१,०६८.२४
-२९.५७
-२.६९%
—१,०९७.८११,०८७.७६१,०८७.७६१,०६७.४२——
SIXC
Communications
SIXC
Communications
SIXC
-०.८९%
६०६.५९
-५.४४
-०.८९%
—६१२.०३६१२.०३६१२.०३६०६.१३——
SIXE
Energy
SIXE
Energy
SIXE
+२.१९%
१,२४७.२१
+२६.७८
+२.१९%
—१,२२०.४३१,२२१.९९१,२४७.६०१,२२१.९९——
SIXI
Industrials
SIXI
Industrials
SIXI
-१.८२%
१,७२७.५८
-३१.९४
-१.८२%
—१,७५९.५२१,७५४.३११,७५४.३११,७२३.६०——
SIXM
Financials
SIXM
Financials
SIXM
-०.३२%
६२९.५४
-२.००
-०.३२%
—६३१.५४६३१.२७६३३.९९६२८.६३——
SIXR
Staples
SIXR
Staples
SIXR
-०.४२%
८५३.६०
-३.५६
-०.४२%
—८५७.१६८५८.९१८६१.७१८५२.३३——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-१.५६%
२१२.०४
-३.३७
-१.५६%
—२१५.४१२१५.४१२१५.४१२११.८८——
SIXT
Technology
SIXT
Technology
SIXT
-१.७८%
३,५४९.७६
-६४.३९
-१.७८%
—३,६१४.१५३,५५६.२४३,५९८.३६३,५१६.८६——
SIXU
Utilities
SIXU
Utilities
SIXU
-२.४०%
८८६.४९
-२१.८१
-२.४०%
—९०८.३०९०६.५५९०६.५५८८५.८८——
SIXV
Health care
SIXV
Health care
SIXV
-१.०८%
१,४६४.३४
-१६.०६
-१.०८%
—१,४८०.४०१,४७९.५५१,४८४.४३१,४६२.५२——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-१.८४%
२,३५४.२५
-४४.१२
-१.८४%
—२,३९८.३७२,३७३.०९२,३७३.०९२,३५०.२७——
GMAB:NASDAQ
Genmab A/S - ADR
US$ २६.५४
-१.३४%
(-०.३६) 1D
US$ २६.५४
०.००% (०.००)
After hours
Closed: मे १५, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMAB...
Open
US$ २६.८४
High
US$ २६.९६
Low
US$ २६.४४
Mkt. cap
१६.२४ अरब
Avg. vol.
१८.४३ लाख
Volume
१३.६२ लाख
P/E ratio
२०.१०
52-wk high
US$ ३५.४३
52-wk low
US$ १९.५९
EPS
US$ १.३२
Beta
०.८६
Shares outstanding
६२.३५ करोड
No. of employees
३ हजार
News stories
From sources across the web
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees३.०९ हजार
Founded१९९९
Headquarters-
Sector-
Websitegenmab.com
Last report
२०२६ मे ७
Fiscal Period
Q1 2026
EPS / Est. (DKK)
- / DKK ८.२३
Revenue / Est. (DKK)
५.६९ अरब / ५.६५ अरब
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
२०२३ डिसेम्बर
२०२४ मार्च
२०२४ जुन
२०२४ सेप्टेम्बर
Revenue
४.६८ अरब
४.१४ अरब
५.४० अरब
५.५४ अरब
Cost of goods sold
-
-
-
२७.३० करोड
Cost of revenue
-
-
-
२७.३० करोड
Research and development expenses
-
-
-
२.२८ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
८६.५० करोड
Operating expense
-
-
-
३.१५ अरब
Total operating expenses
-
-
-
३.४२ अरब
Operating income
-
-
-
२.१२ अरब
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
१.७२ अरब
EBT excluding unusual items
-
-
-
१.५९ अरब
Income tax expense
-
-
-
४५.३० करोड
Effective tax rate
-
-
-
२६.३५%
Other operating expenses
-
-
-
-
Net income
-
-
-
१.२७ अरब
Net profit margin
-
-
-
२२.८५%
Earnings per share
९.६७
-
-
१९.८१
Interest and investment income
-
-
-
१६.२० करोड
Interest expense
-
-
-
-१.८० करोड
Net interest expenses
-
-
-
१४.४० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
२.२० अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer